- CRS Publications
- News
News
Date:
This article summarizes selected patents in the area of controlled release or delivery that were issued from August 31, 2021 through December 7, 2021. Greater detail on each of these patents is given on the U.S. patent website https://patft.uspto.gov.…
Date:
Members of the Women in Science executive board met in December to plan 2022 activities. From top to bottom, left to right: Maria Jose Alonso, Andrea Joseph, Sujuan Ba, Ruth Schmid, Sara Cordeiro, Renata F. V. Lopez, Nidhi Raval, Danchen Gao, and Ana Cadete.…
Date:
Business Wire: August 7, 2017 – JERUSALEM, Israel – Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that the U.S. Food and Drug Administration (FDA) has approved QVAR® RediHaler™ (beclomethasone dipropionate HFA) inhalation aerosol, a breath-actuated inhaler for the…
Authors:
Date:
PRNewswire: May 16, 2017 – PARIS, France – Micell Technologies announced today at the late-breaking trial session of EuroPCR— the official congress of the European Association of Percutaneous Cardiovascular Interventions—positive 12 month data from its DESSOLVE III clinical trial. The study met its…
Authors:
Date:
Business Wire: May 16, 2017 – PARIS, France – Final 5-year outcomes from the DIRECT first-in-man study were presented at the EuroPCR symposium today, with 0% clinically driven target lesion revascularization (TLR), target vessel failure (TVF), and major adverse cardiac events (MACE) reported. The…
Authors:
Date:
PRNewswire: May 13, 2017 – KANSAS CITY, KS, U.S.A. – Cingulate Therapeutics, LLC, a privately held biopharmaceutical company focused on the development of new and innovative products for the treatment of attention deficit/hyperactivity disorder (ADHD), is proud to announce its transition to a…
